Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Study suggests link between binge drinking and risk of dementia in older adults

Researchers from the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, will present the findings of a new study suggesting a link between binge drinking in older adults and the risk of developing dementia.

18 Jul 2012

New Alzheimer's model derived from skin cells of patients may prove to be more accurate

Researchers at the Alzheimer's Association International Conference 2012 (AAIC 2012) today reported the creation of a new model of Alzheimer's derived from the skin cells of people with the disease that were reprogramed into Alzheimer's brain cells.

17 Jul 2012

Researchers examine YouTube database to find most viewed videos for nurses and nursing

The nursing profession needs to harness the power of the video-sharing website YouTube to promote a positive image of nurses, after research found that many of the top hits portray them in a derogatory way. That is the key finding of research published in the August issue of the Journal of Advanced Nursing.

17 Jul 2012

Scientists discover new way to convert cord blood cells into iNC

For more than 20 years, doctors have been using cells from blood that remains in the placenta and umbilical cord after childbirth to treat a variety of illnesses, from cancer and immune disorders to blood and metabolic diseases.

17 Jul 2012

PsychoGenics, Afraxis partner to offer Enhanced Spine Platform technology

Afraxis and PsychoGenics today announced an alliance to offer Afraxis' Enhanced Spine Platform (ESP) technology as part of PsychoGenics' comprehensive testing capabilities and drug discovery services.

17 Jul 2012

Scientists develop first cell-based model of Alzheimer's disease

A team of scientists at The New York Stem Cell Foundation (NYSCF) Laboratory led by Scott Noggle, PhD, NYSCF-Charles Evans Senior Research Fellow for Alzheimer's Disease, has developed the first cell-based model of Alzheimer's disease (AD) by reprogramming skin cells of Alzheimer's patients to become brain cells that are affected in Alzheimer's.

17 Jul 2012

Genetic tests for Alzheimer’s disease a comfort for the majority

Several genetic tests are available for Alzheimer’s disease, both for the general public and for those with a family history of the disease. As direct-to-consumer testing over the internet rises, so have concerns over how people will handle information related to their risk of developing Alzheimer’s disease.

17 Jul 2012

People with amnestic MCI more likely to die

Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found that people with a form of mild cognitive impairment (MCI), a risk factor for developing Alzheimer's disease, have twice the risk of dying compared with cognitively normal people. Those with dementia have three times the risk.

17 Jul 2012

Studies provide evidence of connections between MCI and negative health outcomes

Two studies presented today at the Alzheimer's Association International Conference 2012 (AAIC 2012) in Vancouver provide evidence of connections between mild cognitive impairment (MCI) and negative health outcomes – increased isolation and death.

17 Jul 2012

Merck to present results from clinical studies on BACE inhibitors at AAIC 2012

Merck, known as MSD outside the United States and Canada, announced today presentations at the upcoming Alzheimer's Association International Conference (AAIC) being held in Vancouver, British Columbia, Canada on July 14-19, 2012.

16 Jul 2012

Gait disturbances could indicate a decline in cognitive function

Gait disturbances – such as a slowing of walking pace or a more variable stride – could indicate a decline in cognitive function, according to new research studies reported today at the Alzheimer's Association's International Conference 2012 (AAIC 2012).

16 Jul 2012

Studies describe ability of targeted exercise training on cognitive impairment and dementia

Four studies reported today at the Alzheimer's Association International Conference 2012 (AAIC 2012) describe the ability of targeted exercise training to promote improved mental functioning and reduced risk for cognitive impairment and dementia in cognitively healthy older adults and those with mild cognitive impairment (MCI).

16 Jul 2012

The Alzheimer's Association recognizes four leading scientists with Lifetime Achievement Award

The Alzheimer's Association recognized four leading scientists for their extraordinary contributions to Alzheimer's disease research at the Alzheimer's Association International Conference (AAIC 2012) in Vancouver, Canada.

16 Jul 2012

Varying brain activity may reduce risk of Alzheimer's disease

Activity lingers longer in certain areas of the brain in those with Alzheimer's than it does in healthy people, Mayo Clinic researchers who created a map of the brain found. The results suggest varying brain activity may reduce the risk of Alzheimer's disease. The study, "Non-stationarity in the "Resting Brain's" Modular Architecture," was presented at the Alzheimer's Association International Conference and recently published in the journal PLoS One.

16 Jul 2012

Alzheimer's Association honors Gladstone researcher with Lifetime Achievement Award

Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research. The Alzheimer's Association presented the award to Dr. Mucke today at the 2012 Alzheimer's Association International Conference (AAIC) in Vancouver, Canada.

16 Jul 2012

Researchers link newly discovered gene mutations to ALS

Researchers have linked newly discovered gene mutations to some cases of the progressive fatal neurological disease amyotrophic lateral sclerosis - ALS, also known as Lou Gehrig's disease. Shedding light on how ALS destroys the cells and leads to paralysis, the researchers found that mutations in this gene affect the structure and growth of nerve cells.

16 Jul 2012

James J. Peters Veterans Hospital actively enrolls participants for NIC5-15 phase IIb trial in AD

The James J. Peters Veterans Hospital in Bronx, New York, is actively recruiting participants for a phase IIb clinical trial testing NIC5-15, a disease modifying candidate for Alzheimer's disease.

14 Jul 2012

MedStar NRH, Georgetown University create new Center for Brain Plasticity and Recovery

Georgetown University and MedStar National Rehabilitation Network announced today a new research and patient care partnership that extends the boundaries of neuroscience. The new Center for Brain Plasticity and Recovery marks the launch of a rare research continuum spanning basic and translational science in brain recovery.

14 Jul 2012

Chica and Heinz Schaller Foundation supports work of five new C.H.S. research groups

Five new research groups for young scientists, the C.H.S. research groups, have taken up their work in basic biomedical research. To mark the occasion, the German Cancer Research Center (DKFZ) will hold a ceremony on 20 July 2012.

14 Jul 2012

PGC-1alpha and TFEB provide two new therapeutic targets for Huntington's disease

In a paper published in the July 11 online issue of Science Translational Medicine, researchers at the University of California, San Diego School of Medicine have identified two key regulatory proteins critical to clearing away misfolded proteins that accumulate and cause the progressive, deadly neurodegeneration of Huntington's disease.

12 Jul 2012

Alzheimer's Disease News and Research

Further Reading

Study suggests link between binge drinking and risk of dementia in older adults

New Alzheimer's model derived from skin cells of patients may prove to be more accurate

Researchers examine YouTube database to find most viewed videos for nurses and nursing

Scientists discover new way to convert cord blood cells into iNC

PsychoGenics, Afraxis partner to offer Enhanced Spine Platform technology

Scientists develop first cell-based model of Alzheimer's disease

Genetic tests for Alzheimer’s disease a comfort for the majority

People with amnestic MCI more likely to die

Studies provide evidence of connections between MCI and negative health outcomes

Merck to present results from clinical studies on BACE inhibitors at AAIC 2012

Gait disturbances could indicate a decline in cognitive function

Studies describe ability of targeted exercise training on cognitive impairment and dementia

The Alzheimer's Association recognizes four leading scientists with Lifetime Achievement Award

Varying brain activity may reduce risk of Alzheimer's disease

Alzheimer's Association honors Gladstone researcher with Lifetime Achievement Award

Researchers link newly discovered gene mutations to ALS

James J. Peters Veterans Hospital actively enrolls participants for NIC5-15 phase IIb trial in AD

MedStar NRH, Georgetown University create new Center for Brain Plasticity and Recovery

Chica and Heinz Schaller Foundation supports work of five new C.H.S. research groups

PGC-1alpha and TFEB provide two new therapeutic targets for Huntington's disease

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News